TYK2 activity promotes ligand-induced IFNAR1 proteolysis

被引:68
作者
Marijanovic, Zrinka
Ragimbeau, Josiane
Kumar, K. G. Suresh
Fuchs, Serge Y.
Pellegrini, Sandra
机构
[1] Inst Pasteur, Cytokine Signalling Unit, CNRS, URA 1961, F-75724 Paris, France
[2] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA
关键词
degradation; interferon-alpha receptor I subunit (IFNAR1); internalization; Tyk2; type I interferon (IFN); ubiquitination;
D O I
10.1042/BJ20060272
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The type I IFNR (interferon receptor) is a heterodimer composed of two transmembrane chains, IFNAR1 (interferon-alpha receptor I subunit) and IFNAR2, which are associated with the tyrosine kinases Tyk2 and Jak1 (Janus kinase 1) respectively. Ligand-induced down-regulation of the type I IFNR is a major mechanism of negative regulation of cellular signalling and involves the internalization and lysosomal degradation of IFNAR1 IFN alpha promotes the, phosphorylation of IFNAR1 on Ser(535), followed by recruitment of the E3 ubiquitin ligase, beta-TrCP2 ( beta-transducin repeats-containing protein 2), ubiquitination of IFNAR1 and proteolysis. The non-catalytic role of Tyk2 in sustaining the steady-state IFNAR1 level at the plasma membrane is well documented;however, little is known about the function of Tyk2 in the steps that precede and succeed serine phosphorylation and ubiquitination of IFNAR1 in response to ligand binding. In the present study, we show that catalytic activation of Tyk2 is not essential for IFNAR1 internalization, but is required for ligand-induced IFNAR1 serine phosphorylation, ubiquitination and efficient lysosomal proteolysis.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 42 条
[11]   Endosomal dynamics of Met determine signaling output [J].
Hammond, DE ;
Carter, S ;
McCullough, J ;
Urbé, S ;
Vande Woude, G ;
Clague, MJ .
MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (04) :1346-1354
[12]   ENDOCYTOSIS OF INTERLEUKIN-2 RECEPTORS IN HUMAN T-LYMPHOCYTES - DISTINCT INTRACELLULAR-LOCALIZATION AND FATE OF THE RECEPTOR ALPHA-CHAIN, BETA-CHAIN, AND GAMMA-CHAIN [J].
HEMAR, A ;
SUBTIL, A ;
LIEB, M ;
MORELON, E ;
HELLIO, R ;
DAUTRYVARSAT, A .
JOURNAL OF CELL BIOLOGY, 1995, 129 (01) :55-64
[13]  
Höller D, 2004, BIOCHEM PHARMACOL, V67, P1013, DOI 10.1016/j.bcp.2004.01.003
[14]   The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor [J].
Huang, LJS ;
Constantinescu, SN ;
Lodish, HF .
MOLECULAR CELL, 2001, 8 (06) :1327-1338
[15]   Receptor downregulation and multivesicular-body sorting [J].
Katzmann, DJ ;
Odorizzi, G ;
Emr, SD .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (12) :893-905
[16]   Signaling through the JAK/STAT pathway, recent advances and future challenges [J].
Kisseleva, T ;
Bhattacharya, S ;
Braunstein, J ;
Schindler, CW .
GENE, 2002, 285 (1-2) :1-24
[17]   Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes [J].
Kotenko, SV ;
Pestka, S .
ONCOGENE, 2000, 19 (21) :2557-2565
[18]   Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor [J].
Kumar, KGS ;
Krolewski, JJ ;
Fuchs, SY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (45) :46614-46620
[19]  
Kumar KGS, 2003, EMBO J, V22, P5480
[20]   Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway [J].
Lamaze, C ;
Dujeancourt, A ;
Baba, T ;
Lo, CG ;
Benmerah, A ;
Dautry-Varsat, A .
MOLECULAR CELL, 2001, 7 (03) :661-671